First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study.
- Resource Type
- Article
- Source
- Breast; Jun2021, Vol. 57, p104-112, 9p
- Subject
METASTATIC breast cancer LOG-rank test CYCLIN-dependent kinases HORMONE therapy SURVIVAL analysis (Biometry) MULTIVARIATE analysis - Language
- ISSN
- 09609776